Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.

Navratilova E, Nation K, Remeniuk B, Neugebauer V, Bannister K, Dickenson AH, Porreca F.

Pain. 2019 Nov 8. doi: 10.1097/j.pain.0000000000001748. [Epub ahead of print]

PMID:
31725062
2.
3.

Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.

Mazzitelli M, Neugebauer V.

Neuropharmacology. 2019 Nov 1;158:107706. doi: 10.1016/j.neuropharm.2019.107706. Epub 2019 Jul 12.

PMID:
31306647
4.

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain.

Boccella S, Marabese I, Iannotta M, Belardo C, Neugebauer V, Mazzitelli M, Pieretti G, Maione S, Palazzo E.

Int J Mol Sci. 2019 Apr 9;20(7). pii: E1757. doi: 10.3390/ijms20071757.

5.

Editorial: Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders.

Palazzo E, Neugebauer V, Maione S.

Front Mol Neurosci. 2019 Mar 22;12:67. doi: 10.3389/fnmol.2019.00067. eCollection 2019. No abstract available.

6.

Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.

Navratilova E, Ji G, Phelps C, Qu C, Hein M, Yakhnitsa V, Neugebauer V, Porreca F.

Pain. 2019 Apr;160(4):824-832. doi: 10.1097/j.pain.0000000000001458.

7.

Cortico-limbic pain mechanisms.

Thompson JM, Neugebauer V.

Neurosci Lett. 2019 May 29;702:15-23. doi: 10.1016/j.neulet.2018.11.037. Epub 2018 Nov 29. Review.

PMID:
30503916
8.

Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation.

Mazzitelli M, Palazzo E, Maione S, Neugebauer V.

Front Mol Neurosci. 2018 Oct 9;11:383. doi: 10.3389/fnmol.2018.00383. eCollection 2018. Review.

9.

Fear extinction learning ability predicts neuropathic pain behaviors and amygdala activity in male rats.

Ji G, Yakhnitsa V, Kiritoshi T, Presto P, Neugebauer V.

Mol Pain. 2018 Jan-Dec;14:1744806918804441. doi: 10.1177/1744806918804441. Epub 2018 Sep 13.

10.

Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats.

Thompson JM, Yakhnitsa V, Ji G, Neugebauer V.

Neuropharmacology. 2018 Aug;138:219-231. doi: 10.1016/j.neuropharm.2018.06.015. Epub 2018 Jun 13.

11.

Pathway-Specific Alterations of Cortico-Amygdala Transmission in an Arthritis Pain Model.

Kiritoshi T, Neugebauer V.

ACS Chem Neurosci. 2018 Sep 19;9(9):2252-2261. doi: 10.1021/acschemneuro.8b00022. Epub 2018 Apr 13.

12.

Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain.

Nation KM, De Felice M, Hernandez PI, Dodick DW, Neugebauer V, Navratilova E, Porreca F.

Pain. 2018 May;159(5):919-928. doi: 10.1097/j.pain.0000000000001167.

13.

Amygdala Plasticity and Pain.

Thompson JM, Neugebauer V.

Pain Res Manag. 2017;2017:8296501. doi: 10.1155/2017/8296501. Epub 2017 Dec 10. Review.

14.

Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model.

Kim H, Thompson J, Ji G, Ganapathy V, Neugebauer V.

Pain. 2017 Dec;158(12):2376-2385. doi: 10.1097/j.pain.0000000000001042.

15.

The cannabinoid system and pain.

Woodhams SG, Chapman V, Finn DP, Hohmann AG, Neugebauer V.

Neuropharmacology. 2017 Sep 15;124:105-120. doi: 10.1016/j.neuropharm.2017.06.015. Epub 2017 Jun 15. Review.

16.

Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.

Bhutia YD, Kopel JJ, Lawrence JJ, Neugebauer V, Ganapathy V.

Molecules. 2017 Feb 28;22(3). pii: E378. doi: 10.3390/molecules22030378. Review.

17.

5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors.

Ji G, Zhang W, Mahimainathan L, Narasimhan M, Kiritoshi T, Fan X, Wang J, Green TA, Neugebauer V.

J Neurosci. 2017 Feb 8;37(6):1378-1393. doi: 10.1523/JNEUROSCI.2468-16.2016. Epub 2016 Dec 23.

18.

Differential contributions of vasopressin V1A and oxytocin receptors in the amygdala to pain-related behaviors in rats.

Cragg B, Ji G, Neugebauer V.

Mol Pain. 2016 Nov 11;12. pii: 1744806916676491. Print 2016.

19.

Distinct contributions of reactive oxygen species in amygdala to bee venom-induced spontaneous pain-related behaviors.

Lu YF, Neugebauer V, Chen J, Li Z.

Neurosci Lett. 2016 Apr 21;619:68-72. doi: 10.1016/j.neulet.2016.03.015. Epub 2016 Mar 10.

20.

Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection.

Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, Jennings K, Gelman B.

J Neuroimmune Pharmacol. 2016 Jun;11(2):279-93. doi: 10.1007/s11481-016-9652-2. Epub 2016 Jan 30.

21.

Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats.

Kiritoshi T, Ji G, Neugebauer V.

J Neurosci. 2016 Jan 20;36(3):837-50. doi: 10.1523/JNEUROSCI.4047-15.2016.

23.

Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.

Kiritoshi T, Neugebauer V.

Neuropharmacology. 2015 Aug;95:388-94. doi: 10.1016/j.neuropharm.2015.04.003. Epub 2015 Apr 22.

24.

Amygdala pain mechanisms.

Neugebauer V.

Handb Exp Pharmacol. 2015;227:261-84. doi: 10.1007/978-3-662-46450-2_13. Review.

25.

A Wnt5a signaling pathway in the pathogenesis of HIV-1 gp120-induced pain.

Yuan SB, Ji G, Li B, Andersson T, Neugebauer V, Tang SJ.

Pain. 2015 Jul;156(7):1311-9. doi: 10.1097/j.pain.0000000000000177.

26.

Reactive oxygen species mediate visceral pain-related amygdala plasticity and behaviors.

Ji G, Li Z, Neugebauer V.

Pain. 2015 May;156(5):825-36. doi: 10.1097/j.pain.0000000000000120.

27.

Nasal application of neuropeptide S inhibits arthritis pain-related behaviors through an action in the amygdala.

Medina G, Ji G, Grégoire S, Neugebauer V.

Mol Pain. 2014 May 29;10:32. doi: 10.1186/1744-8069-10-32.

28.
29.

Neural mechanisms of pain and alcohol dependence.

Apkarian AV, Neugebauer V, Koob G, Edwards S, Levine JD, Ferrari L, Egli M, Regunathan S.

Pharmacol Biochem Behav. 2013 Nov;112:34-41. doi: 10.1016/j.pbb.2013.09.008. Epub 2013 Oct 2. Review.

30.

5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain.

Grégoire S, Neugebauer V.

Mol Pain. 2013 Aug 12;9:41. doi: 10.1186/1744-8069-9-41.

31.

Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors.

Ren W, Kiritoshi T, Grégoire S, Ji G, Guerrini R, Calo G, Neugebauer V.

J Neurophysiol. 2013 Oct;110(8):1765-81. doi: 10.1152/jn.00874.2012. Epub 2013 Jul 24.

32.

Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.

Ji G, Fu Y, Adwanikar H, Neugebauer V.

Mol Pain. 2013 Feb 15;9:2. doi: 10.1186/1744-8069-9-2.

33.

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau.

Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V, Jackson GR, Kayed R.

Sci Rep. 2012;2:700. doi: 10.1038/srep00700. Epub 2012 Oct 3.

34.

Modulation of medial prefrontal cortical activity using in vivo recordings and optogenetics.

Ji G, Neugebauer V.

Mol Brain. 2012 Oct 8;5:36. doi: 10.1186/1756-6606-5-36.

35.

Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.

Kiritoshi T, Sun H, Ren W, Stauffer SR, Lindsley CW, Conn PJ, Neugebauer V.

Neuropharmacology. 2013 Mar;66:170-8. doi: 10.1016/j.neuropharm.2012.03.024. Epub 2012 Apr 6.

36.

α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Martin ZS, Neugebauer V, Dineley KT, Kayed R, Zhang W, Reese LC, Taglialatela G.

J Neurochem. 2012 Feb;120(3):440-52. doi: 10.1111/j.1471-4159.2011.07576.x. Epub 2011 Nov 28.

37.

Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA(A) receptors.

Ji G, Neugebauer V.

J Neurophysiol. 2011 Nov;106(5):2642-52. doi: 10.1152/jn.00461.2011. Epub 2011 Aug 31.

38.

Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.

Ren W, Palazzo E, Maione S, Neugebauer V.

Neuropharmacology. 2011 Dec;61(8):1334-44. doi: 10.1016/j.neuropharm.2011.08.006. Epub 2011 Aug 16.

39.

mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making.

Sun H, Neugebauer V.

J Neurophysiol. 2011 Aug;106(2):960-73. doi: 10.1152/jn.00762.2010. Epub 2011 May 25.

40.

Homer1a signaling in the amygdala counteracts pain-related synaptic plasticity, mGluR1 function and pain behaviors.

Tappe-Theodor A, Fu Y, Kuner R, Neugebauer V.

Mol Pain. 2011 May 19;7:38. doi: 10.1186/1744-8069-7-38.

41.
43.

Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice.

Dineley KT, Kayed R, Neugebauer V, Fu Y, Zhang W, Reese LC, Taglialatela G.

J Neurosci Res. 2010 Oct;88(13):2923-32. doi: 10.1002/jnr.22445.

44.

Reactive oxygen species are involved in group I mGluR-mediated facilitation of nociceptive processing in amygdala neurons.

Ji G, Neugebauer V.

J Neurophysiol. 2010 Jul;104(1):218-29. doi: 10.1152/jn.00223.2010. Epub 2010 May 12.

45.

Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation.

Ji G, Sun H, Fu Y, Li Z, Pais-Vieira M, Galhardo V, Neugebauer V.

J Neurosci. 2010 Apr 14;30(15):5451-64. doi: 10.1523/JNEUROSCI.0225-10.2010.

46.

Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.

Han JS, Adwanikar H, Li Z, Ji G, Neugebauer V.

Mol Pain. 2010 Feb 8;6:10. doi: 10.1186/1744-8069-6-10.

47.

Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization.

Pernía-Andrade AJ, Kato A, Witschi R, Nyilas R, Katona I, Freund TF, Watanabe M, Filitz J, Koppert W, Schüttler J, Ji G, Neugebauer V, Marsicano G, Lutz B, Vanegas H, Zeilhofer HU.

Science. 2009 Aug 7;325(5941):760-4. doi: 10.1126/science.1171870.

48.

Hemispheric lateralization of pain processing by amygdala neurons.

Ji G, Neugebauer V.

J Neurophysiol. 2009 Oct;102(4):2253-64. doi: 10.1152/jn.00166.2009. Epub 2009 Jul 22.

49.

Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength.

Lei G, Anastasio NC, Fu Y, Neugebauer V, Johnson KM.

J Neurochem. 2009 May;109(4):1017-30. doi: 10.1111/j.1471-4159.2009.06030.x. Epub 2009 Mar 10.

50.

NR2B receptor blockade inhibits pain-related sensitization of amygdala neurons.

Ji G, Horváth C, Neugebauer V.

Mol Pain. 2009 Apr 28;5:21. doi: 10.1186/1744-8069-5-21.

Supplemental Content

Loading ...
Support Center